Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : OTC)

• Company Description    Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $14.00 Daily Weekly Monthly 20 Day Moving Average: 543 shares Shares Outstanding: 3.88 (millions) Market Capitalization: $54.31 (millions) Beta: -0.03 52 Week High: $22.15 52 Week Low: $9.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.38% 14.25% 12 Week -3.38% -10.45% Year To Date -34.88% -43.86%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2125 BUTTERFIELD DRIVE SUITE 100 - TROY,MI 48084 USA ph: 248-452-9866 fax: - tpatel@allianceadvisors.com http://www.zivobioscience.com

• General Corporate Information    Officers John B. Payne - Chief Executive Officer; President and Director Keith R. Marchiando - Chief Financial Officer; and Secretary Christopher D. Maggiore - Director Nola E. Masterson - Director Alison A. Cornell - Director Peer Information ZIVO Bioscience, Inc. (CORR.) ZIVO Bioscience, Inc. (RSPI) ZIVO Bioscience, Inc. (CGXP) ZIVO Bioscience, Inc. (BGEN) ZIVO Bioscience, Inc. (GTBP) ZIVO Bioscience, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 98978N309 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 3.88 Most Recent Split Date: 10.00 (0.17:1) Beta: -0.03 Market Capitalization: $54.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 84.53% vs. Previous Quarter: 61.61% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/25 - - 06/30/25 - - 03/31/25 - - ROA 09/30/25 - - 06/30/25 - -931.80 03/31/25 - -1,613.15 Current Ratio 09/30/25 - - 06/30/25 - 0.14 03/31/25 - 0.39 Quick Ratio 09/30/25 - - 06/30/25 - 0.14 03/31/25 - 0.39 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - -5,555.43 03/31/25 - -13,375.41 Book Value 09/30/25 - - 06/30/25 - -0.67 03/31/25 - -0.42 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©